Efficacy and Safety of Switching to Dolutegravir with Boosted Darunavir in Virologically Suppressed Adults with HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: the DUALIS Study
Open Forum Infectious Diseases(2020)
关键词
darunavir,dolutegravir,efficacy and safety,switch,HIV
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要